GLENWOOD, Ill., April 24, 2012 /PRNewswire/ -- Landauer, Inc. (NYSE: LDR), will release financial results for the fiscal second quarter 2012 after the market close on Monday, May 7, 2012.
The company will host a conference call for investors on Tuesday, May 8, 2012, at 9:00 a.m. Central Time ( 10 a.m. Eastern Time). Investors may access the live call by dialing 877-941-2332 (within the United States and Canada), or 480-629-9867 (international callers), or by visiting the "Investors" page on the company's website at www.landauerinc.com. Please log on to the website at least 15 minutes early to register, download and install any necessary audio software.
Investors may access a replay of the call by dialing 800-406-7325 (within the United States and Canada), or 303-590-3030 (international callers), passcode 4534716#, which will be available through Friday, June 8, 2012. The replay will also be available on Landauer's website for 90 days following the call.
About LandauerLandauer is a leading global provider of technical and analytical services to determine occupational and environmental radiation exposure and is the leading domestic provider of outsourced medical physics services. For more than 50 years, the Company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries in which radiation poses a potential threat to employees. Landauer's services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from customers, and the analysis and reporting of exposure findings. The Company provides its dosimetry services to approximately 1.7 million individuals globally. In addition, through its Global Physics Solutions subsidiary, the Company provides therapeutic and imaging physics services to the medical physics community. Through its IZI Medical Products subsidiary, the Company provides medical consumable accessories used in radiology, radiation therapy, and image guided surgery procedures.